Leukemia Lymphocytic Acute (ALL) in Relapse
1 clinical trials · Condition
◉ Watch Leukemia Lymphocytic Acute (ALL) in Relapse
| Record | Firm | Date |
|---|---|---|
| CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma. (NCT04037566) | Xijing Hospital | 2019-08-01 |
Track Leukemia Lymphocytic Acute (ALL) in Relapse automatically
Every clearance here is in the API, with alerts when new ones post.